Avivagen Inc. added Aubrey Dan to the board.
Dan is the principal of the Dancap Family Investment Office.
The board appointment is subject to the approval of the TSX Venture Exchange.
Avivagen appoints director
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Avivagen Inc. added Aubrey Dan to the board.
Dan is the principal of the Dancap Family Investment Office.
The board appointment is subject to the approval of the TSX Venture Exchange.